Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01631435 · ClinicalTrials.gov registry record · Phase 1
PillCam® Platform With the PillCam Crohn's Disease Capsule
A Phase 1 study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
NCT01631435 is a Phase 1 study that has completed, run by Medtronic - MITG. The registered enrollment target is 75 participants.
The verdict
NCT01631435, a Phase 1 study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
This is a prospective, multi-center (up to 6 sites) study which aims to To establish the effectiveness of the PillCam Platform with the PillCam Crohn's capsule as demonstrated by visualizing the small bowel and colon in patients with active symptoms associated with Crohn's disease (CD).
Interventions
- OTHER Pillcam colon capsule and PillCam™ Prep Procedure
- DEVICE Ileocolonoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01631435
The ClinicalTrials.gov registry entry for NCT01631435 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pillcam colon capsule and PillCam™ Prep Procedure is the first listed.
NCT01631435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01631435 about?
NCT01631435 is a clinical study titled "PillCam® Platform With the PillCam Crohn's Disease Capsule". This is a prospective, multi-center (up to 6 sites) study which aims to To establish the effectiveness of the PillCam Platform with the PillCam Crohn's capsule as demonstrated by visualizing the small bowel and colon in patients with active symptoms associated with Crohn's disease (CD).
What is the current status of trial NCT01631435?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2012-06. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01631435?
The interventions under investigation include: Pillcam colon capsule and PillCam™ Prep Procedure (OTHER), Ileocolonoscopy (DEVICE).
Who is sponsoring clinical trial NCT01631435?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.